research report · MET

Metlife Inc

Johannes Vermeer, Woman Holding a Balance, c. 1664, detail · National Gallery of Art

Viridis’s deep research report, written Nov 6, 2026 from its quarterly report (10-Q for the quarter ended Sep 30, 2026, filed Nov 6, 2026). Written and checked with Anthropic’s Claude models.

your email, no card; what you get

business trajectory

Improving

better on balance: sales, margins, cash or competitive position

financial resilience

Strong

can meet its obligations and fund its plan for two years with money it can count on, with room

Judgments of the business from its filings, not of its shares: no valuation, no advice.

bottom line

MetLife's businesses grew in the third quarter of 2026, but more slowly than the record $2.85 of adjusted earnings per share excluding notable items suggests. Variable investment income (VII: private equity, real estate funds and prepayment fees) was $720M pre-tax, against a $400M quarterly pace in guidance. By my calculation, its rise explains about 72% of the increase in adjusted earnings excluding notable items. That leaves core growth near 5%, or about 9% per share after buybacks. Net income to common shareholders nearly tripled to $2,351M, mostly on a rate-driven accounting gain, while the same higher rates cut book value per share 22% to $30.73. Capital is not a constraint: holding companies held $3.4B of liquid assets, inside their $3–4B target.

what changed this quarter

  • Adjusted earnings available to common shareholders rose 12% to $1,780M, or $2.78 a share, up 17%. Excluding notable items they were $1,826M, up 17%. Net income to common was $2,351M against $818M.
  • Premiums, fees and other revenues rose 12% to $14.1B. Excluding pension risk transfers (PRT, company pension plans taken over), adjusted revenue rose 8%, with growth in all six segments.
  • Guidance:
  • VII is on course to exceed the ~$1.6B full-year guide.
  • RIS full-year earnings are expected slightly above the midpoint of $1.6–1.8B, assuming normal Q4 VII.
  • The 12.1% direct expense ratio target for 2026 and 11.3% for 2029 were kept.
  • About $1.0B was returned in the quarter ($650M of buybacks, $380M of dividends), plus $265M of buybacks in October. A new $3.0B authorization had $2,972M left at September 30.
  • The annual actuarial assumption review and other insurance adjustments cut adjusted earnings by $46M.

in the full report

Its findings, each with the evidence, the strongest counterpoint and what would prove it wrong:

  • Record per-share earnings rest on investment income, low claims and buybacks; core growth was about 5%
  • Net income's jump is mostly a rate-driven accounting gain, and the same rates cut book value by a fifth
  • Commercial property losses grew in the third quarter
  • Asset-management growth is still bought; clients withdrew more than they added

Then its finances, the quality of its earnings, its management, the case for and against, and what to watch, its claims cited to the filings and checked against them.

read it whole

Your email and the code we send it, no card. The report then opens: a free account has 2 free reports a month from the library, the reports already written. Already have a Viridis account? Use its email, and the report goes on it. You also see what MET files, free: its deadlines and its red flags.

Subscribe: your plan’s reports work on any company that files with the SEC, written for you if nobody has asked yet, and each new one on the companies you choose comes as they file.

In Claude or ChatGPT, ask: “What does Viridis's report on MET say?” Add Viridis to Claude, or to ChatGPT.